• Amyloid-beta PET and CSF in an autopsy-confirmed cohortReimand, Juhan; Boon, Baayla D.C.; Collij, Lyduine E.; Teunissen, Charlotte E.; Rozemuller, Annemieke J.M.; Van Berckel, Bart N.M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeAnnals of clinical and translational neurology2020 / p. 2150−2160 https://doi.org/10.1002/acn3.51195 https://www.scopus.com/sourceid/21100823147 https://www.scopus.com/record/display.uri?eid=2-s2.0-85092711232&origin=inward&txGid=632d5a82f14ec02d45a449c9de416844 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=ANN%20CLIN%20TRANSL%20NEUR&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000579558600001
• Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkersOssenkoppele, Rik; Reimand, Juhan; Smith, Ruben; Leuzy, Antoine; Strandberg, Olof; Palmqvist, Sebastian; Stomrud, Erik; Zetterberg, HenrikEMBO Molecular Medicine2021 / art. e14398 https://doi.org/10.15252/emmm.202114398 https://www.scopus.com/sourceid/19600166310 https://www.scopus.com/record/display.uri?eid=2-s2.0-85111722211&origin=inward&txGid=488b678e1a72d29a1ef76f6e15ef7357 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=EMBO%20MOL%20MED&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000672472500001
• Why is amyloid-β PET requested after performing CSF biomarkers?Reimand, Juhan; Groot, Colin; Teunissen, Charlotte E.; Windhorst, Albert D.; Boellaard, Ronald; Barkhof, Frederike; Nazarenko, Sergei; van der Flier, Wiesje M.; Scheltens, Philip; Ossenkoppele, Rik; Bouwman, FemkeJournal of Alzheimer's disease2020 / p. 559-569 https://doi.org/10.3233/JAD-190836 https://www.scopus.com/sourceid/16246 https://www.scopus.com/record/display.uri?eid=2-s2.0-85078507057&origin=inward&txGid=00d41882032da9684bcf6453fabe39df https://jcr.clarivate.com/jcr-jp/journal-profile?journal=J%20ALZHEIMERS%20DIS&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000512318900012